August 15, 2018
Former Skyscanner Chief Technology Officer Dr Alistair Hann has joined NHS Scotland to help build a national digital platform aiming to improve access to information for both citizens and health and care staff and remove interoperability barriers.
In his new role as CTO of the NHS Digital Service, based within NHS Education for Scotland, Dr Hann will work with Geoff Huggins, Director of Health...
23andMe kits at a Beverly Hills event in 2017. Credit: Matt Winkelmeyer, Getty Images
July 25, 2018
23andMe on Wednesday announced that GlaxoSmithKline has invested $300 million to gain exclusive access to the genetic testing startup’s DNA database.
The deal comes as GlaxoSmithKline amid reports that GSK is weighing the possibility of a company breakup and investors contending that synergies between consumer markets and big pharma are inherently limited and that GSK’s pharmaceuticals business...
July 19, 2018
California-based telehealth provider InTouch Health inked a letter of intent alongside Rite Aid to explore how the virtual care platform can be implemented by the retail pharmacy chain to boost customers’ access to care.
Specifically, the deal looks to bring InTouch’s technology to health kiosks owned by Rite Aid. These kiosks could be placed in Rite Aid’s pharmacies, or installed in “alternative...
July 17, 2018
As Johnson & Johnson continues to move out of the diabetes business, the company has sold its Calibra product (marketed as OneTouch Via, but never launched) to CeQur, a 10-year-old company working on a similar insulin-delivery wearable. Terms of the deal were not disclosed, but CeQur has acquired an exclusive worldwide license for the technology.
“They’re divesting out of the diabetes market...
July 6, 2018
Pharma companies are getting more and more open about their digital health initiatives, which has given MobiHealthNews more opportunities this quarter than usual to chronicle pharma’s efforts around adherence, clinical trials, and the burgeoning world of digital therapeutics. In addition, at the BIO conference in Boston this quarter MobiHealthNews heard pharma innovation leaders share their...
June 22, 2018
Medication management and adherence app maker Medisafe has announced a partnership with Boehringer Ingelheim following a successful pilot.
Medisafe will offer a wraparound app experience that incorporates Pradaxa-specific educational information into a special version of its app, which patients will be directed to when they're prescribed the drug.
"Pradaxa is not different than any other...
June 22, 2018
HIMSS announced that it is now accepting speaker proposals for the upcoming HIMSS19 Global Conference.
“HIMSS seeks topics that focus on the good and not so good organizational experiences that highlight the similarities in global transformative healthcare practices,” HIMSS Vice President of Professional Development JoAnn Klinedinst wrote on the association’s website.
Specifically, HIMSS is...
June 19, 2018
A ground-breaking facility that will harness Artificial Intelligence to develop new drugs for clinical testing within weeks is to be opened through investment from the new £103m Rosalind Franklin Institute (RFI).
Funded by the government through UK Research and Innovation, the RFI will use advanced technologies such as AI and robotics to transform the drug discovery process and create new...
June 12, 2018
Biogen has just launched a new app, called Aby, aimed at giving people living with multiple sclerosis (MS) accurate and reliable information about the condition and support.
The app is free and gives users articles, tips and inspirations about living with the condition. It also provides patients a personal journal, where they can create custom treatment reminders, track appointments, and record...
June 12, 2018
Medidata, a New York City-based company that offers cloud storage and data analytics services for clinical trials, announced today that it has acquired Shyft Analytics, maker of a cloud data analytics platform specifically designed for the pharma and biotech industries.
The transaction valued Shyft at $195 million, inclusive of Medidata’s prior 6 percent ownership in the analytics platform, to be...